J. van de Loo

2.9k total citations · 1 hit paper
48 papers, 2.2k citations indexed

About

J. van de Loo is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Epidemiology. According to data from OpenAlex, J. van de Loo has authored 48 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Hematology and 13 papers in Epidemiology. Recurrent topics in J. van de Loo's work include Blood properties and coagulation (8 papers), Neutropenia and Cancer Infections (8 papers) and Platelet Disorders and Treatments (7 papers). J. van de Loo is often cited by papers focused on Blood properties and coagulation (8 papers), Neutropenia and Cancer Infections (8 papers) and Platelet Disorders and Treatments (7 papers). J. van de Loo collaborates with scholars based in Germany, Switzerland and United Kingdom. J. van de Loo's co-authors include Leopold Balleisen, H. Schulte, Gerd Assmann, J. J. Heinrich, Helmut Ostermann, Jessica N. Cooke Bailey, P. H. Epping, M. von Eiff, N. Roos and M. Zühlsdorf and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and CHEST Journal.

In The Last Decade

J. van de Loo

44 papers receiving 2.1k citations

Hit Papers

Fibrinogen and factor VII in the prediction of coronary r... 1994 2026 2004 2015 1994 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. van de Loo Germany 19 959 838 660 418 353 48 2.2k
A. Sturk Netherlands 16 268 0.3× 442 0.5× 540 0.8× 220 0.5× 92 0.3× 35 1.9k
A Bensman France 33 752 0.8× 294 0.4× 271 0.4× 67 0.2× 153 0.4× 133 3.3k
Verena Schroeder Switzerland 25 740 0.8× 825 1.0× 197 0.3× 133 0.3× 97 0.3× 60 1.7k
Huy P. Pham United States 18 269 0.3× 773 0.9× 209 0.3× 134 0.3× 82 0.2× 91 2.4k
Namık Yaşar Özbek Türkiye 21 269 0.3× 634 0.8× 313 0.5× 87 0.2× 42 0.1× 206 1.7k
A Ciaccia Italy 19 980 1.0× 372 0.4× 276 0.4× 88 0.2× 140 0.4× 51 2.2k
Toshiaki Ikeda Japan 23 289 0.3× 227 0.3× 1.2k 1.8× 191 0.5× 43 0.1× 72 2.0k
C. Merskey United States 21 743 0.8× 1.2k 1.4× 145 0.2× 235 0.6× 104 0.3× 54 2.2k
Osman Özcebe Türkiye 21 179 0.2× 661 0.8× 169 0.3× 168 0.4× 41 0.1× 141 1.6k
Teresa Quiroga Chile 20 220 0.2× 827 1.0× 99 0.1× 278 0.7× 114 0.3× 50 1.5k

Countries citing papers authored by J. van de Loo

Since Specialization
Citations

This map shows the geographic impact of J. van de Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. van de Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. van de Loo more than expected).

Fields of papers citing papers by J. van de Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. van de Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. van de Loo. The network helps show where J. van de Loo may publish in the future.

Co-authorship network of co-authors of J. van de Loo

This figure shows the co-authorship network connecting the top 25 collaborators of J. van de Loo. A scholar is included among the top collaborators of J. van de Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. van de Loo. J. van de Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Michael, et al.. (2008). Stellenwert der Chemotherapie in der multimodalen Behandlung des nicht-kleinzelligen Bronchialkarzinomes. DMW - Deutsche Medizinische Wochenschrift. 120(47). 1627–1630.
2.
Schumacher, Andrea, Achim Heinecke, Cristina Sauerland, et al.. (2002). Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia. Leukemia Research. 26(4). 355–362. 52 indexed citations
3.
4.
Cassens, U., Henk Garritsen, Reinhard Kelsch, et al.. (1997). Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure. Bone Marrow Transplantation. 19(8). 835–840. 12 indexed citations
5.
Eiff, M. von, N. Roos, W. Fegeler, et al.. (1996). Hospital-acquired candida and aspergillus pneumonia—diagnostic approaches and clinical findings. Journal of Hospital Infection. 32(1). 17–28. 18 indexed citations
6.
Eiff, M. von, M. Zühlsdorf, N. Roos, et al.. (1995). Pulmonary infiltrates in patients with haematologic malignancies: Clinical usefulness of non‐invasive bronchoscopic procedures. European Journal Of Haematology. 54(3). 157–162. 41 indexed citations
7.
Eiff, M. von, M. Zühlsdorf, N. Roos, et al.. (1995). Pulmonary fungal infections in patients with hematological malignancies — Diagnostic approaches. Annals of Hematology. 70(3). 135–141. 44 indexed citations
8.
Thomas, Michael, M. von Eiff, Burkhard Brandt, Achim Heinecke, & J. van de Loo. (1995). Immunophenotyping of Lymphocytes in Bronchoalveolar Lavage Fluid. CHEST Journal. 108(2). 464–469. 18 indexed citations
9.
Eiff, M. von, N. Roos, R. Schulten, et al.. (1995). Pulmonary Aspergillosis: Early Diagnosis Improves Survival. Respiration. 62(6). 341–347. 277 indexed citations
11.
Loo, J. van de. (1995). CIRCULATING FACTORS OF THE HAEMOSTATIC SYSTEMS AS INDICATORS OF INCREASED OR REDUCED CORONARY RISK. British Journal of Haematology. 91(4). 777–782. 8 indexed citations
12.
Eiff, M. von, et al.. (1994). Pulmonary fungal infections in immunocompromised patients: incidence and risk factors. Mycoses. 37(9-10). 329–335. 23 indexed citations
13.
Ostermann, Helmut, Markus Rothenburger, Rolf M. Mesters, J. van de Loo, & J Kienast. (1994). Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. British Journal of Haematology. 88(2). 332–337. 41 indexed citations
14.
Kehrel, Beate E., et al.. (1992). A Simple and Rapid Immunomagnetobead Technique for the Analysis of Platelet Glycoprotein Deficiencies. Platelets. 3(2). 91–93. 1 indexed citations
16.
Hiddemann, Wolfgang, et al.. (1991). Alpha interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone. European Journal of Cancer and Clinical Oncology. 27. S37–S39. 3 indexed citations
17.
Eiff, M. von, M. Essink, N. Roos, et al.. (1990). Hepatosplenic Candidiasis in Acute Leukemias. Hämatologie und Bluttransfusion. 33. 555–557. 2 indexed citations
18.
Schulte, H., et al.. (1985). Influence of Low Molecular Weight Heparin on the Hemostatic System After Abdominal Surgery. Thrombosis and Haemostasis. 53(3). 297–300. 2 indexed citations
19.
Lechler, E., F Asbeck, & J. van de Loo. (1975). Diagnostik der Verbrauchskoagulopathie. DMW - Deutsche Medizinische Wochenschrift. 100(1). 22–24. 2 indexed citations
20.
McNicol, G. P., et al.. (1974). Platelets in Thrombosis Their Clinical Significance and the Evaluation of Potential Drugs. Thrombosis and Haemostasis. 31(3). 379–394. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026